CliffBio
small molecule

VISICOL

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Loss of exclusivity—loss of exclusivity
CompanySalix Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameVISICOL
Active ingredientSODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Strength0.398GM;1.102GM
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2000
Marketing statusDISCN

More from Salix Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.